Breast Cancer Trial, Recruiting NCT06523894 Sponsor: University Hospital, Geneva Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT06523894
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are over 70 years of age
  • People who have a confirmed breast cancer diagnosis (confirmed through a tissue sample), at any point before joining the study
  • People whose overall physical functioning falls within a certain range, from fully active to limited self-care ability (confirm with trial site)
  • People whose medical team has decided, through a group specialist discussion, that surgery is not suitable for them, or who have chosen not to have surgery
  • People who have a measurable area of breast cancer that can be seen clearly on imaging such as ultrasound, CT, or MRI
  • People whose breast tumor can be targeted with a specialised type of radiation treatment called SBRT, as determined by the treating radiation specialist
  • People who are receiving or have received drug treatment for their breast cancer before this study (neo-adjuvant systemic therapy) are still able to participate
  • People whose tumor size, as seen on a planning CT scan, is suitable for SBRT delivery, as determined by the treating radiation specialist
  • People who have more than two tumor areas within the same part of the breast, as long as the total area to be treated is still considered suitable for SBRT by the treating radiation specialist
  • People where the total tumor volume does not make up more than 30% of the whole breast volume
  • People who have previously had breast cancer treatment to the other breast, or previous treatment to the same breast for a reason other than breast cancer
  • People who are able to cooperate with the requirements of the radiation treatment process
  • People who are able to understand and sign a written consent form before joining the study

Who may not be able to join:

  • People who have already had surgery for their current breast cancer diagnosis
  • People who have previously had radiation treatment to the affected breast, whether to the whole breast or part of it
  • People who have a medical condition that means radiation treatment is completely unsuitable for them (for example, a condition called Li-Fraumeni syndrome)
  • People who are currently taking part in another clinical trial involving an experimental treatment or device, or who have done so within the 4 weeks before the first day of this treatment
  • People who are not able to communicate meaningfully with the study team, or who are not able to give informed consent
  • People who have other serious medical, mental health, personal, or location-related circumstances that the study team believes could interfere with treatment, follow-up, or safety

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Pelagia Tsoutsou, Pr, Radiation Oncology Department, Geneva University Hospital

Phone: 0795534630

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University Hospital, Geneva
Registry
ClinicalTrials.gov
Start date
25 March 2025
Est. completion
25 March 2028

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

Maximum Tolerated Dose (MTD)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov